NDC 63323-258-01 - Methylprednisolone Sodium Succinate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-258
- Requested NDC
- 63323-258-01
- Package NDCs from labels
- 63323-258-01, 63323-258-03
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2024-03-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Methylprednisolone Sodium Succinate - REMEDYREPACK INC. | REMEDYREPACK INC. | 2024-03-12 | HUMAN PRESCRIPTION DRUG LABEL |
| Methylprednisolone Sodium Succinate - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2023-03-02 | HUMAN PRESCRIPTION DRUG LABEL |
| methylPREDNISolone Sodium Succinate for Injection, USP | REMEDYREPACK INC. | 2020-11-16 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-258-01 | Methylprednisolone Sodium Succinate | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 2 | 7 | |
| 63323-258-03 | Methylprednisolone Sodium Succinate | 25 in 1 TRAY | INJECTION, POWDER, LYOPHILIZED, | 25 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-258 | METHYLPREDNISOLONE SODIUM SUCCINATE (METHYLPREDNISOLONE SODIUM SUCCINATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC ] | 7 | Current NDC, Legacy NDC, 2 package rows | 20230509_c5d22210-73c6-4697-a267-75e243508642.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-258-01 | EA - Each | 63323-258 | 1ab8bf02-6730-4148-9b7c-4caf12626fca | 1 | 2024-07-12 |
| 63323-258-03 | EA - Each | 63323-258 | 5689026c-6fa7-45f5-ab08-a9eb9d879c9d | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methylprednisolone Sodium Succinate | METHYLPREDNISOLONE SODIUM SUCCINATE | Civica, Inc. | 2e6020f5-a486-41cc-8956-58b5f6751aa2 | 2026-02-17 | Warnings, Adverse reactions | 1743704 311659 LEC9GKY20K |
| Methylprednisolone Sodium Succinate | METHYLPREDNISOLONE SODIUM SUCCINATE | Hikma Pharmaceuticals USA Inc. | 05d95a56-b03a-4d5b-9877-2853ac470fa1 | 2026-02-13 | Warnings, Adverse reactions | 1743704 311659 LEC9GKY20K |
| Methylprednisolone Sodium Succinate | METHYLPREDNISOLONE SODIUM SUCCINATE | Hikma Pharmaceuticals USA Inc. | 2e540674-0915-4498-8e2b-751c7e97532a | 2026-02-13 | Warnings, Adverse reactions | 314099 LEC9GKY20K |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | REMEDYREPACK INC. | 1d5ef347-2e9a-432f-9a88-a7c4ba300267 | 2026-01-30 | Warnings, Adverse reactions | 1743704 LEC9GKY20K |
| Solu-Medrol | METHYLPREDNISOLONE SODIUM SUCCINATE | Cardinal Health 107, LLC | 7e38b09c-da41-4ee3-8f99-812d3276d551 | 2025-12-19 | Warnings, Adverse reactions | 311659 LEC9GKY20K |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | ProPharma Distribution | 42df21df-9284-4505-e063-6294a90a7024 | 2025-12-18 | Warnings, Adverse reactions | 311659 LEC9GKY20K |
| Hepatatox | TRITICUM AESTIVUM, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE, GLUTATHIONE, HEPAR SUIS, THYROIDINUM (SUIS), LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORICUM ACIDUM, ADRENOCORTICOTROPHIN, SALICYLICUM ACIDUM, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM POTASSIUM SORBATE, SORBITOL, RESORCINUM, BENZYL ALCOHOL, LACTICUM ACIDUM, ISOPROPYL PALMITATE, BORICUM ACIDUM, ACETICUM ACIDUM, PHENYL BUTAZONE, PETROLEUM JELLY, PLUMBUM METALLICUM | BioActive Nutritional, Inc | a113a9f1-4792-41a5-8d1b-a6756f356e15 | 2025-12-18 | Warnings | LKG8494WBH |
| Methylprednisolone Sodium Succinate | METHYLPREDNISOLONE | Tianjin Kingyork Pharmaceuticals Co., Ltd | 77a8d96c-37df-4f3a-9757-b2d4131ff82b | 2025-12-18 | Warnings, Adverse reactions | 1743704 314099 311659 LEC9GKY20K |
| Methylprednisolone Sodium Succinate | METHYLPREDNISOLONE | Amneal Pharmaceuticals LLC | e86fbda8-00e4-4d54-841a-59dea6c15e70 | 2025-12-15 | Warnings, Adverse reactions | 1743704 311659 LEC9GKY20K |
| Thermacare Max Strength Lidocaine | THERMACARE MAX STRENGTH LIDOCAINE | Clarion Brands LLC | 44fed887-d1e0-d205-e063-6294a90ac416 | 2025-12-02 | Warnings | LKG8494WBH |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | Pharmacia & Upjohn Company LLC | cd99be87-c8d9-48d6-a8e5-e081052e3f19 | 2025-12-02 | Warnings, Adverse reactions | 1743704 314099 311659 LEC9GKY20K |
| Thermacare Heat Therapy Max Strength Lidocaine Pain Relief Rollon | THERMACARE HEAT THERAPY MAX STRENGTH LIDOCAINE PAIN RELIEF ROLLON | Clarion Brands LLC | 4482d34d-eaca-5522-e063-6394a90a6afb | 2025-11-26 | Warnings | LKG8494WBH |
| Thermacare Heat Therapy Max Strength Lidocaine Pain Relief Gel | THERMACARE HEAT THERAPY MAX STRENGTH LIDOCAINE PAIN RELIEF GEL | Clarion Brands LLC | 445db02a-c8e8-6ebb-e063-6294a90a4301 | 2025-11-24 | Warnings | LKG8494WBH |
| Zilactin Early Relief Cold Sore | BENZYL ALCOHOL | ASCENT CONSUMER PRODUCTS, INC | 42ef8bfa-c4d9-01cf-e063-6394a90ac88a | 2025-11-06 | Warnings | LKG8494WBH |
| Uro-MP | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE | Method Pharmaceuticals, LLC | 1e1b0dee-1a3b-4846-a212-c9febb3fc17d | 2025-10-29 | Warnings, Adverse reactions | KH7I04HPUU |
| Schuessler Tissue Salts Comb 12 General Tonic | CALCAREA FLUORICA,CALCAREA PHOSPHORICA,CALCAREA SULPHURICA,FERRUM PHOSPHORICUM,KALI PHOSPHORICUM,KALI MURIATICUM,KALI SULPHURICUM,MAGNESIA PHOSPHORICA,NATRUM MURIATICUM,NATRUM PHOSPHORICUM,NATRUM SULPHURICUM,SILICEA | Martin & Pleasance Pty Ltd | 9083a01b-2fbe-4e04-9eec-bf4f65950ec7 | 2025-09-09 | Warnings | 22ADO53M6F |
| Schuessler Tissue Salts Comb 12 General Tonic | CALCAREA FLUORICA,CALCAREA PHOSPHORICA,CALCAREA SULPHURICA,FERRUM PHOSPHORICUM ,KALI PHOSPHORICUM,KALI MURIATICUM,KALI SULPHURICUM,MAGNESIA PHOSPHORICA,NATRUM MURIATICUM,NATRUM PHOSPHORICUM,NATRUM SULPHURICUM,SILICEA | Martin & Pleasance Pty Ltd | c14c79ab-85bb-45f2-83d1-1d9c298ffdfd | 2025-09-08 | Warnings | 22ADO53M6F |
| Schuessler Tissue Salts Comb 5 Nerve Tonic | CALCAREA PHOSPHORICA,MAGNESIA PHOSPHORICA,FERRUM PHOSPHORICUM ,NATRUM PHOSPHORICUM,KALI PHOSPHORICUM | Martin & Pleasance Pty Ltd | 7fd350ec-af99-4eb2-8750-226edc7f24b0 | 2025-08-13 | Warnings | 22ADO53M6F |
| Schuessler Tissue Salts Comb 5 Nerve Tonic | CALCAREA PHOSPHORICA ,MAGNESIA PHOSPHORICA,FERRUM PHOSPHORICUM,NATRUM PHOSPHORICUM,KALI PHOSPHORICUM | Martin & Pleasance Pty Ltd | c0df631e-2935-4d55-a3c9-ee04ffdbe6fd | 2025-08-13 | Warnings | 22ADO53M6F |
| Sodium Phosphates | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE AND SODIUM PHOSPHATE, DIBASIC ANHYDROUS | Civica, Inc. | 8fd901e6-30cb-411a-b820-b9e79625ec7c | 2025-08-08 | Warnings, Adverse reactions | 22ADO53M6F |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.